Form 4: Natera CEO Sells Shares Under 10b5-1 Plan

Natera CEO and President Steven Leonard Chapman sold 89,024 shares of common stock in early February 2026, primarily under a pre-arranged 10b5-1 trading plan.

Summary

• Steven Leonard Chapman, Natera's CEO and President, reported sales of Natera, Inc. common stock.
• A total of 89,024 shares were sold across multiple transactions on February 2 and February 3, 2026.
• The sales on February 2, 2026, totaling 85,299 shares, were executed under a Rule 10b5-1 trading plan established on December 11, 2023, and amended on December 2, 2024.
• An additional 4,725 shares were sold on February 3, 2026, to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) granted on January 31, 2025, also under a 10b5-1 plan.
• Following these transactions, Chapman directly beneficially owns 123,156 shares of Natera common stock.
• The weighted average sale prices ranged from $229.0846 to $233.3118 per share for the 10b5-1 plan sales, and $230.768 for the tax-related sale.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While the sales are pre-planned and partially tax-related, the substantial reduction in the CEO's direct holdings could be interpreted with caution by investors.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive disposition of shares.
• A portion of the sales was specifically for tax withholding related to RSU vesting, which is a common and expected event for executive compensation.

Negatives

• Significant insider selling, even if pre-planned, can sometimes be perceived negatively by the market, potentially signaling a desire to diversify holdings or a lack of confidence.
• The total number of shares sold (89,024) represents a notable reduction in the CEO's direct beneficial ownership from 206,549 shares to 123,156 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Natera's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales by top executives, are closely watched by investors for signals about a company's prospects. While sales under a 10b5-1 plan are pre-scheduled and designed to avoid accusations of trading on material non-public information, a significant volume of sales can still influence market sentiment, especially in the biotechnology and diagnostics sector where Natera operates, which is often sensitive to executive confidence.

Stakeholder Impact

• Shareholders: May interpret the sales as a signal, potentially impacting stock price perception.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

The sales by Natera's CEO, while significant, were conducted under a pre-arranged 10b5-1 plan and partially for tax obligations, which mitigates the negative signal. This suggests a planned diversification or liquidity event rather than an immediate loss of confidence in the company's prospects. Investors should monitor future filings and company performance for more definitive signals, maintaining a 'hold' position based solely on this Form 4.

Keywords

Natera, NTRA, Steven Leonard Chapman, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Restricted Stock Units, Tax Withholding